Hemab Therapeutics Holdings, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Keli Walbert, a Director of Hemab Therapeutics Holdings, Inc., received 36,000 shares of common stock on September 24, 2026.